Gaël Roué

22PUBLICATIONS
140CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 10, 2026
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption.

|Oct 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández, Alexander J Dimitri, Fang Chen

|Mar 18, 2025
Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma.

Corentin Bouvier, Maria Gonzalez-Santamarta, Núria Profitós-Pelejà

|Sep 14, 2024
Applying Molecular Modeling to the Design of Innovative, Non-Symmetrical CXCR4 Inhibitors with Potent Anticancer Activity.

Miquel Martínez-Asensio, Lluís Sàrrias, Gema Gorjón-de-Pablo

|Feb 01, 2024
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy.

Ignacio Campillo-Marcos, Marta Casado-Pelaez, Veronica Davalos

|Jun 05, 2023
Epigenetic targets in B- and T-cell lymphomas: latest developments.

Marcelo Lima Ribeiro, Salvador Sánchez Vinces, Laura Mondragon

Pageof 4

Frequent Collaborators

6 joint publications

Núria Profitós-Pelejà

6 joint publications

Juliana Carvalho Santos

6 joint publications

Miranda Fernández-Serrano

4 joint publications

Brigitte Sola